REFERENCES
1. Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol 2018;72:2625-41.
2. Vancheri F, Longo G, Vancheri S, Henein M. Coronary microvascular dysfunction. J Clin Med 2020;9:2880.
3. Corcoran D, Young R, Adlam D, et al. Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study. Int J Cardiol 2018;266:7-14.
4. Izzo P, Macchi A, De Gennaro L, Gaglione A, Di Biase M, Brunetti ND. Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options. Eur Heart J Acute Cardiovasc Care 2012;1:158-69.
5. D'Amario D, Migliaro S, Borovac JA, et al. Microvascular dysfunction in heart failure with preserved ejection fraction. Front Physiol 2019;10:1347.
6. Montone RA, Meucci MC, De Vita A, Lanza GA, Niccoli G. Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications. Atherosclerosis 2020;318:14-21.
7. Geraghty L, Figtree GA, Schutte AE, Patel S, Woodward M, Arnott C. Cardiovascular disease in women: from pathophysiology to novel and emerging risk factors. Heart Lung Circ 2021;30:9-17.
8. Raut BK, Patil VN, Cherian G. Coronary artery dimensions in normal Indians. Indian Heart J 2017;69:512-4.
9. Goodwill AG, Dick GM, Kiel AM, Tune JD. Regulation of coronary blood flow. Compr Physiol 2017;7:321-82.
10. Kumar A, D'Souza SS, Moskvin OV, et al. Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts. Cell Rep 2017;19:1902-16.
11. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
12. Porter KE, Riches K. Vascular smooth muscle as a target for novel therapeutics. Curr Diab Rep 2015;15:72.
13. Lee SJ, Lee IK, Jeon JH. Vascular calcification-new insights into its mechanism. Int J Mol Sci 2020;21:2685.
14. Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res 2016;118:692-702.
15. Fazal L, Azibani F, Vodovar N, Cohen Solal A, Delcayre C, Samuel J-L. Effects of biological sex on the pathophysiology of the heart. Br J Pharmacol 2014;171:555-66.
16. Monk BA, George SJ. The effect of ageing on vascular smooth muscle cell behaviour - a mini-review. Gerontology 2015;61:416-26.
17. Tykocki NR, Boerman EM, Jackson WF. Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles. Compr Physiol 2017;7:485-581.
18. Liu Y, Drozdov I, Shroff R, Beltran LE, Shanahan CM. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ Res 2013;112:e99-109.
19. Thompson AM, Wagner R, Rzucidlo EM. Age-related loss of SirT1 expression results in dysregulated human vascular smooth muscle cell function. Am J Physiol Heart Circ Physiol 2014;307:H533-41.
20. Schutzer WE, Reed JF, Mader SL. Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. Am J Physiol Heart Circ Physiol 2005;288:H2457-64.
21. DuPont JJ, Kim SK, Kenney RM, Jaffe IZ. Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor. Am J Physiol Heart Circ Physiol 2021;320:H169-80.
22. Climie RE, van Sloten TT, Bruno RM, et al. Macrovasculature and microvasculature at the crossroads between type 2 diabetes mellitus and hypertension. Hypertension 2019;73:1138-49.
23. Bai H, McCaig CD, Forrester JV, Zhao M. DC electric fields induce distinct preangiogenic responses in microvascular and macrovascular cells. Arterioscler Thromb Vasc Biol 2004;24:1234-9.
24. Gräfe M, Auch-Schwelk W, Hertel H, et al. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis 1998;137:87-95.
25. Kelly JJ, Moore TM, Babal P, Diwan AH, Stevens T, Thompson WJ. Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+ and permeability. Am J Physiol 1998;274:L810-9.
26. Riches K, Warburton P, O'Regan DJ, Turner NA, Porter KE. Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity. Cardiovasc Revasc Med 2014;15:141-8.
27. McCallinhart PE, Cho Y, Sun Z, Ghadiali S, Meininger GA, Trask AJ. Reduced stiffness and augmented traction force in type 2 diabetic coronary microvascular smooth muscle. Am J Physiol Heart Circ Physiol 2020;318:H1410-9.
28. Sulgin AA, Sidorova TN, Sidorov VY. Growth and characterization of a tissue-engineered construct from human coronary artery smooth muscle cells. Biulleten Sib Meditsiny 2020;19:85-95.
29. Mokelke EA, Dietz NJ, Eckman DM, Nelson MT, Sturek M. Diabetic dyslipidemia and exercise affect coronary tone and differential regulation of conduit and microvessel K+ current. Am J Physiol Heart Circ Physiol 2005;288:H1233-41.
30. Bychkov R, Gollasch M, Ried C, Luft FC, Haller H. Regulation of spontaneous transient outward potassium currents in human coronary arteries. Circulation 1997;95:503-10.
31. Miura H, Toyama K, Pratt PF, Gutterman DD. Cigarette smoking impairs Na+-K+-ATPase activity in the human coronary microcirculation. Am J Physiol Heart Circ Physiol 2011;300:H109-17.
32. Miura H, Liu Y, Gutterman DD. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation 1999;99:3132-8.
33. Zhao G, Joca HC, Nelson MT, Lederer WJ. ATP- and voltage-dependent electro-metabolic signaling regulates blood flow in heart. Proc Natl Acad Sci U S A 2020;117:7461-70.
34. Cabrera JTO, Si R, Makino A. Gap junction intercellular communication and coronary microvascular disease in Type 2 diabetes. FASEB 2020;34:1.
35. Osamichi S, Kouji K, Yoshimaro I, et al. Myocardial glucose metabolism assessed by positron emission tomography and the histopathologic findings of microvessels in syndrome X. Circ J 2004;68:220-6.
36. Lindemann H, Petrovic I, Hill S, et al. Biopsy-confirmed endothelial cell activation in patients with coronary microvascular dysfunction. Coron Artery Dis 2018;29:216-22.
37. Madi HA, Riches K, Warburton P, O'Regan DJ, Turner NA, Porter KE. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients. Am J Physiol Cell Physiol 2009;297:C1307-17.
38. Riches K, Alshanwani AR, Warburton P, et al. Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. J Mol Cell Cardiol 2014;74:240-50.
39. Savinova OV, Liu Y, Aasen GA, et al. Thyroid hormone promotes remodeling of coronary resistance vessels. PLoS One 2011;6:e25054.
40. Lilly B. We have contact: endothelial cell-smooth muscle cell interactions. Physiology (Bethesda) 2014;29:234-41.
41. Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. Gender differences in symptoms of hypothyroidism: a population-based DanThyr study. Clin Endocrinol (Oxf) 2015;83:717-25.
42. Traub-Weidinger T, Graf S, Beheshti M, et al. Coronary vasoreactivity in subjects with thyroid autoimmunity and subclinical hypothyroidism before and after supplementation with thyroxine. Thyroid 2012;22:245-51.
43. Yoneda K, Takasu N, Higa S, et al. Direct effects of thyroid hormones on rat coronary artery: nongenomic effects of triiodothyronine and thyroxine. Thyroid 1998;8:609-13.
44. Lawandy I, Liu Y, Shi G, et al. Increased coronary arteriolar contraction to serotonin in juvenile pigs with metabolic syndrome. Mol Cell Biochem 2019;461:57-64.
45. Climent B, Sánchez A, Moreno L, et al. Underlying mechanisms preserving coronary basal tone and NO-mediated relaxation in obesity: Involvement of β1 subunit-mediated upregulation of BK(Ca) channels. Atherosclerosis 2017;263:227-36.
46. Berwick ZC, Dick GM, O'Leary HA, et al. Contribution of electromechanical coupling between Kv and Ca v1.2 channels to coronary dysfunction in obesity. Basic Res Cardiol 2013;108:370.
47. Lynch FM, Izzard AS, Austin C, et al. Effects of diabetes and hypertension on structure and distensibilty of human small coronary arteries. J Hypertens 2012;30:384-9.
48. Lu T, Chai Q, Jiao G, et al. Downregulation of BK channel function and protein expression in coronary arteriolar smooth muscle cells of type 2 diabetic patients. Cardiovasc Res 2019;115:145-53.
49. Miura H, Wachtel RE, Loberiza FR Jr, et al. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res 2003;92:151-8.
50. Henning C, Branopolski A, Follert P, et al. Endothelial β1 integrin-mediated adaptation to myocardial ischemia. Thromb Haemost 2021; doi: 10.1055/s-0040-1721505.
51. Mosseri M, Nahir M, Rozenman Y, et al. Diffuse narrowing of coronary arteries in diabetic patients: the earliest phase of coronary artery disease. Cardiology 1998;89:103-10.
52. Munnur RK, Nerlekar N, Wong DT. Imaging of coronary atherosclerosis in various susceptible groups. Cardiovasc Diagn Ther 2016;6:382-95.
53. Sakuma H, Yamamoto M, Okumura M, Kojima T, Maruyama T, Yasuda K. High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1/A1. Am J Physiol Cell Physiol 2002;283:C422-8.
54. Lu T, Ye D, He T, Wang XL, Wang HL, Lee HC. Impaired Ca2+-dependent activation of large-conductance Ca2+-activated K+ channels in the coronary artery smooth muscle cells of Zucker Diabetic Fatty rats. Biophys J 2008;95:5165-77.
55. Yi F, Wang H, Chai Q, Wang X, Shen WK, Willis MS, Lee HC, Lu T. Regulation of large conductance Ca2+-activated K+ (BK) channel β1 subunit expression by muscle RING finger protein 1 in diabetic vessels. J Biol Chem 2014;289:10853-64.
56. Ren Y, Xu X, Wang X. Altered mRNA expression of ATP-sensitive and inward rectifier potassium channel subunits in streptozotocin-induced diabetic rat heart and aorta. J Pharmacol Sci 2003;93:478-83.
57. Gupta S, Chough E, Daley J, et al. Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity. Am J Physiol Cell Physiol 2002;282:C560-6.
58. Gupta S, Sussman I, McArthur CS, Tornheim K, Cohen RA, Ruderman NB. Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J Clin Invest 1992;90:727-32.
59. Smith JM, Paulson DJ, Solar SM. Na+/K(+)-ATPase activity in vascular smooth muscle from streptozotocin diabetic rat. Cardiovasc Res 1997;34:137-44.
60. Maile LA, Busby WH, Xi G, et al. An anti-αVβ3 antibody inhibits coronary artery atherosclerosis in diabetic pigs. Atherosclerosis 2017;258:40-50.
61. Kawamura M, Paulsen MJ, Goldstone AB, et al. Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy. Cardiovasc Diabetol 2017;16:142.
62. Tang X, Qian LL, Wang RX, et al. Regulation of coronary arterial large conductance Ca2+-activated K+ channel protein expression and function by n-3 polyunsaturated fatty acids in diabetic rats. J Vasc Res 2017;54:329-43.
63. Labazi H, Teng B, Zhou Z, Mustafa SJ. Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice. J Mol Cell Cardiol 2016;90:30-7.
64. Johnston-Cox HA, Koupenova M, Ravid K. A2 adenosine receptors and vascular pathologies. Arterioscler Thromb Vasc Biol 2012;32:870-8.
65. Berwick ZC, Payne GA, Lynch B, Dick GM, Sturek M, Tune JD. Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels. Microcirculation 2010;17:600-7.
66. Dogan MF, Yildiz O, Arslan SO, Ulusoy KG. Potassium channels in vascular smooth muscle: a pathophysiological and pharmacological perspective. Fundam Clin Pharmacol 2019;33:504-23.
67. Chen Y, Waqar AB, Yan H, Wang Y, Liang J, Fan J. Renovascular hypertension aggravates atherosclerosis in cholesterol-fed rabbits. J Vasc Res 2019;56:28-38.
68. Hayenga HN, Hu JJ, Meyer CA, et al. Differential progressive remodeling of coronary and cerebral arteries and arterioles in an aortic coarctation model of hypertension. Front Physiol 2012;3:420.
69. Loirand G, Pacaud P. Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension. Small GTPases 2014;5:1-10.
70. Zhang Y, Dai L, Wu S, Chen P, Zhao S. Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmonary hypertensive rats. Chin Med J (Engl) 2014;127:869-72.
71. Bai X, Mangum K, Kakoki M, Smithies O, Mack CP, Taylor JM. GRAF3 serves as a blood volume-sensitive rheostat to control smooth muscle contractility and blood pressure. Small GTPases 2020;11:194-203.
72. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002;105:1545-7.
73. Liu B, Hu X, Li Y, et al. Epigenetic down-regulation of BK(Ca) channel by miR-181a contributes to the fetal and neonatal nicotine-mediated exaggerated coronary vascular tone in adult life. Int J Cardiol 2019;281:82-9.
74. Saleheen D, Zhao W, Young R, et al. Loss of cardioprotective effects at the ADAMTS7 locus as a result of gene-smoking interactions. Circulation 2017;135:2336-53.
75. Bengtsson E, Hultman K, Dunér P, et al. ADAMTS-7 is associated with a high-risk plaque phenotype in human atherosclerosis. Sci Rep 2017;7:3753.
76. Wang L, Zheng J, Bai X, et al. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 2009;104:688-98.
77. Huang LH, Zhang PA, He JY, Liu J, Cao YX. DMSO-soluble cigarette smoke particles alter the expression of endothelin B receptor in rat coronary artery. J Vasc Res 2013;50:238-48.
78. Cao L, Zhang Y, Cao YX, Edvinsson L, Xu CB. Cigarette smoke upregulates rat coronary artery endothelin receptors in vivo. PLoS One 2012;7:e33008.
79. Lamping KG, Clothier JL, Eastham CL, Marcus ML. Coronary microvascular response to endothelin is dependent on vessel diameter and route of administration. Am J Physiol 1992;263:H703-9.
80. Tsai SH, Lu G, Xu X, Ren Y, Hein TW, Kuo L. Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy. Cardiovasc Res 2017;113:1329-37.
